Browsing NTNU Open by Author "Holmberg, Dag"
Now showing items 1-8 of 8
-
Adherence to clinical guidelines for Barrett’s esophagus
Holmberg, Dag; Ness-Jensen, Eivind; Mattsson, Fredrik; Lagergren, Jesper (Journal article; Peer reviewed, 2019)Background and aim: Clinical guidelines recommend endoscopy surveillance at given intervals or endoscopic therapy for Barrett’s esophagus with low-grade dysplasia (LGD) and high-grade dysplasia (HGD). Whether these guidelines ... -
Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
Åkerström, Johan Hardvik; Santoni, Giola; von Euler Chelpin, My; Ness-Jensen, Eivind; Kauppila, Joonas H.; Holmberg, Dag; Lagergren, Jesper (Journal article; Peer reviewed, 2023)Background & Aims Antireflux treatment is recommended to reduce esophageal adenocarcinoma in patients with Barrett’s esophagus. Antireflux surgery (fundoplication) counteracts gastroesophageal reflux of all types of ... -
Clinical prediction model for tumor progression in Barrett’s esophagus
Holmberg, Dag; Ness-Jensen, Eivind; Mattsson, Fredrik; Lagergren, Jesper (Journal article; Peer reviewed, 2018)Background Individuals with Barrett’s esophagus (BE) are at increased risk of high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC), but the cost-effectiveness of general surveillance of BE is low. This study ... -
Decreased Risk of Esophageal Adenocarcinoma After Gastric Bypass Surgery in a Cohort Study From 3 Nordic Countries
Hardvik Åkerström, Johan; Santoni, Giola; von Euler Chelpin, My; Chidambaram, Swathikan; Markar, Sheraz R.; Maret-Ouda, John; Ness-Jensen, Eivind; Kauppila, Joonas H.; Holmberg, Dag; Lagergren, Jesper (Journal article, 2023)Objective: The objective of this study was to test the hypothesis that bariatric surgery decreases the risk of esophageal and cardia adenocarcinoma. Background: Obesity is strongly associated with esophageal ... -
Endoscopy for Gastroesophageal Reflux Disease and Survival in Esophageal Adenocarcinoma
Holmberg, Dag; Ness-Jensen, Eivind; Mattsson, Fredrik; Lagergren, Jesper (Peer reviewed; Journal article, 2019)Gastroesophageal reflux disease (GERD) is a risk factor of esophageal adenocarcinoma (EAC) and the most common indication for upper gastrointestinal endoscopy. Yet, whether GERD or endoscopy practice influence survival in ... -
Incidence and mortality in upper gastrointestinal cancer after negative endoscopy for gastroesophageal reflux disease
Holmberg, Dag; Santoni, Giola; von Euler-Chelpin, My; Färkkilä, Martti; Kauppila, Joonas; Maret-Ouda, John; Ness-Jensen, Eivind; Lagergren, Jesper (Peer reviewed; Journal article, 2021)Background and Aims Gastroesophageal reflux disease (GERD) is associated with an increased risk of cancer of the upper gastrointestinal tract. This study aimed to assess whether and to what extent a negative upper endoscopy ... -
Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study
Holmberg, Dag; Santoni, Giola; Euler-Chelpin, My von; Färkkilä, Martti; Kauppila, Joonas H.; Maret-Ouda, John; Ness-Jensen, Eivind; Lagergren, Jesper (Peer reviewed; Journal article, 2023)Objective To assess the incidence rate of oesophageal adenocarcinoma among patients with non-erosive gastro-oesophageal reflux disease compared with the general population. Design Population based cohort study. Setting ... -
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy
Holmberg, Dag; Mattsson, Fredrik; Xie, Shaohua; Ness-Jensen, Eivind; El-Serag, Hashem; Lagergren, Jesper (Peer reviewed; Journal article, 2022)Background There is uncertainty whether long-term use of proton-pump inhibitors can cause gastric adenocarcinoma (GAC) and oesophageal adenocarcinoma (OAC). This study aimed to determine how discontinuation of long-term ...